Endocrinology

Dulaglutide: 12 months on

WEBINAR: Tuesday 27 September 2022, 7.30 - 8.45 pm

Dulaglutide became the first funded GLP1 receptor agonist for the treatment of type 2 diabetes in Aotearoa, New Zealand, in September 2021. Dulaglutide is a potential game-changer in the management of diabetes as it is a potent glucose-lowering agent without causing hypoglycaemia alone and reduces cardiovascular disease and weight independently of its effect on glucose levels.

Dulaglutide and Type 2 Diabetes

WEBINAR 31 August: The role of dulaglutide in diabetes management.

Is it my thyroid doctor?

WEBINAR 21 September: Dr Parvathy Chandra on thyroid disease

Type 2 diabetes: New treatment on the horizon

WEBINAR ARCHIVE: Dr Ole Schmiedel discusses a New Zealand centric context for best practice in diabetes management inclusive of new therapies.

Obesity and risk in COVID-19

WEBINAR 14 July: Obesity and risk in COVID-19 with Rinki Murphy

Type II diabetes in young people

View archived webinar: Dr Steven Miller, Consultant Physician in Endocrinology and Diabetes at North Shore Hospital, Auckland discusses type II diabetes in young people in NZ.

Interpreting unusual thyroid function tests

Thyroid conditions are among the most common endocrine disorders. Laboratory tests are crucial in the diagnosis and management of most of these conditions.

Thyroid function tests (TFTs) are the most commonly ordered endocrine tests in both outpatient and inpatient settings and constitute more than 60% of endocrine tests. In general, it is not difficult to interpret thyroid function tests; however, when the results are discordant or incongruous with the clinical picture, their interpretation can be challenging.

Learning objectives:

Osteoporosis update - Ian Reid

Distinguished Professor Ian Reid talks about Osteoporosis New Zealand's Guidance on Diagnosing and Managing Osteoporosis in New Zealand.

Osteoporosis with Prof Ian Reid

2015: Professor Ian Reid an international expert on bone disease, discusses the latest on osteoporosis. Ian is a Professor of Medicine and Endocrinology at the University of Auckland and an international expert and research award winner in osteoporosis.

Subscribe to Endocrinology